Aurobindo Pharma Ltd. Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Consolidate Quarterly Results

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Net Sales

8,645.90

8,285.70

7,868.14

8,382.12

7,978.52

7,796.07

7,567.02

Other Operating Income

0.00

Total Operating income

8,645.90

8,285.70

7,868.14

8,382.12

7,978.52

7,796.07

7,567.02

Raw Material Cost

2,754.88

2,509.80

2,535.16

2,799.51

2,728.74

2,741.85

2,466.66

Purchase of Finished goods

892.65

846.05

807.80

636.18

823.89

747.03

680.01

(Increase) / Decrease In Stocks

-166.32

-16.99

-103.74

-7.81

-237.22

-278.61

-73.99

Employee Cost

1,310.06

1,277.33

1,228.80

1,162.64

1,131.55

1,109.48

1,071.95

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

2,081.29

1,991.41

1,797.09

1,999.68

1,953.58

1,910.18

1,802.82

Total Expenditure (Excl Depreciation)

6,872.56

6,607.60

6,265.11

6,590.20

6,400.54

6,229.93

5,947.45

Operating Profit (PBDIT) excl Other Income

1,773.34

1,678.10

1,603.03

1,791.92

1,577.98

1,566.14

1,619.57

Other Income

187.64

120.59

105.30

134.81

157.29

136.00

220.93

Operating Profit (PBDIT)

1,960.98

1,798.69

1,708.33

1,926.73

1,735.27

1,702.14

1,840.50

Interest

92.77

95.24

97.75

115.02

118.48

112.70

111.04

Exceptional Items

-65.33

0.00

Gross Profit (PBDT)

1,802.88

1,703.45

1,610.58

1,811.71

1,616.79

1,589.44

1,729.46

Depreciation

464.73

429.19

405.70

444.43

418.53

382.28

404.18

Profit Before Tax

1,338.52

1,275.92

1,206.80

1,335.09

1,199.85

1,207.46

1,323.89

Tax

428.72

427.79

382.60

432.26

354.28

390.51

405.67

Provisions and contingencies

0.00

Profit After Tax

909.43

846.47

822.28

935.02

843.98

816.65

919.61

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

909.43

846.47

822.28

935.02

843.98

816.65

919.61

Share in Profit of Associates

0.37

1.66

1.92

-32.19

1.59

0.30

-1.39

Minority Interest

-0.49

-0.32

-0.55

-0.64

-0.24

-0.43

-1.00

Other related items

0.00

Consolidated Net Profit

910.29

848.45

824.75

903.47

845.81

817.38

919.22

Equity Capital

58.08

58.59

Face Value

1.0

Reserves

0.00

30,820.31

0.00

Earnings per share (EPS)

15.67

14.61

14.2

15.56

14.56

14.07

15.69

Diluted Earnings per share

15.67

14.61

14.2

15.56

14.56

14.0

15.69

Operating Profit Margin (Excl OI)

20.61%

20.37%

20.57%

21.38%

19.99%

20.48%

21.72%

Gross Profit Margin

20.95%

20.68%

20.67%

21.62%

20.48%

20.79%

23.19%

PAT Margin

10.57%

10.3%

10.58%

10.77%

10.71%

10.68%

12.31%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Dec 2025 is 4.35% vs 5.31% in Sep 2025

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2025 is 7.29% vs 2.87% in Sep 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is 5.68% vs 4.68% in Sep 2025

Interest

QoQ Growth in quarter ended Dec 2025 is -2.59% vs -2.57% in Sep 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

Compare Quarterly Results Of Aurobindo Pharma With

Select Peers

Figures in Cr

Consolidate Quarterly Results

Change(INR)

Change(%)

Net Sales

8,645.90

3,567.20

5,078.70

142.37%

Other Operating Income

0.00

Total Operating income

8,645.90

3,567.20

5,078.70

142.37%

Raw Material Cost

2,754.88

553.04

2,201.84

398.13%

Purchase of Finished goods

892.65

411.67

480.98

116.84%

(Increase) / Decrease In Stocks

-166.32

13.28

-179.60

-1,352.41%

Employee Cost

1,310.06

823.71

486.35

59.04%

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

2,081.29

846.07

1,235.22

146.00%

Total Expenditure (Excl Depreciation)

6,872.56

2,647.77

4,224.79

159.56%

Operating Profit (PBDIT) excl Other Income

1,773.34

919.43

853.91

92.87%

Other Income

187.64

72.75

114.89

157.92%

Operating Profit (PBDIT)

1,960.98

992.18

968.80

97.64%

Interest

92.77

157.20

-64.43

-40.99%

Exceptional Items

-65.33

-106.59

41.26

38.71%

Gross Profit (PBDT)

1,802.88

728.39

1,074.49

147.52%

Depreciation

464.73

222.60

242.13

108.77%

Profit Before Tax

1,338.52

509.00

829.52

162.97%

Tax

428.72

95.12

333.60

350.71%

Provisions and contingencies

0.00

Profit After Tax

909.43

410.67

498.76

121.45%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

909.43

410.67

498.76

121.45%

Share in Profit of Associates

0.37

3.21

-2.84

-88.47%

Minority Interest

-0.49

5.13

-5.62

-109.55%

Other related items

0.00

Consolidated Net Profit

910.29

408.75

501.54

122.70%

Equity Capital

58.08

41.28

16.80

40.70%

Face Value

1.00

0.00

Reserves

0.00

Earnings per share (EPS)

15.67

9.90

5.77

58.28%

Diluted Earnings per share

15.67

9.89

5.78

58.44%

Operating Profit Margin (Excl OI)

20.61%

25.77%

0.00

-5.16%

Gross Profit Margin

20.95%

20.42%

0.00

0.53%

PAT Margin

10.57%

11.60%

0.00

-1.03%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 8,645.90 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is 4.35% vs 5.31% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 8.36% vs 8.53% in Dec 2024

Quarterly - Consolidate Net Profit

Consolidate Net Profit 910.29 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is 7.29% vs 2.87% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 7.62% vs -9.66% in Dec 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 1,773.34 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is 5.68% vs 4.68% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 12.38% vs -1.46% in Dec 2024

Quarterly - Interest

Interest 92.77 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is -2.59% vs -2.57% in Sep 2025

YoY Growth in quarter ended Dec 2025 is -21.70% vs 56.82% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 20.61%

in Dec 2025

Figures in %

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024